<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Dopamine agonists therapy &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/dopamine-agonists-therapy/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Mon, 29 Dec 2025 21:23:41 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>Dopamine agonists therapy &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>Retrospective Study on Prolactinoma Management in Postmenopausal Women</title>
		<link>https://bioengineer.org/retrospective-study-on-prolactinoma-management-in-postmenopausal-women/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Mon, 29 Dec 2025 21:23:34 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[Dopamine agonists therapy]]></category>
		<category><![CDATA[İşte 5 adet uygun etiket: **Prolactinoma management]]></category>
		<category><![CDATA[Postmenopausal Women]]></category>
		<category><![CDATA[Retrospective study]]></category>
		<category><![CDATA[Women's endocrine health** **Açıklama:** 1. **Prolactinoma management:** Makalenin ana konusu prolaktinoma yönetimi. 2. **Postmenopausal women:** Çalışmanın odaklandığı spesifik hasta popülasyonu. 3.]]></category>
		<guid isPermaLink="false">https://bioengineer.org/retrospective-study-on-prolactinoma-management-in-postmenopausal-women/</guid>

					<description><![CDATA[In the evolving landscape of healthcare, the management of prolactinomas, particularly among postmenopausal women, has emerged as a critical area of study. This type of pituitary tumor, which secretes excessive levels of prolactin, poses unique challenges that require specialized approaches tailored to the demographic’s specific needs. The recent research by Chen et al. highlights the [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">312184</post-id>	</item>
	</channel>
</rss>
